High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP
高单核细胞 MDSC 特征可预测接受 R-CHOP 治疗的非霍奇金淋巴瘤患者的多药耐药性和癌症复发
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2023.1303959
Sukanya Dhar, Mohona Chakravarti, Nilanjan Ganguly, Akata Saha, Shayani Dasgupta, Saurav Bera, Anirban Sarkar, Kamalika Roy, Juhina Das, Avishek Bhuniya, Sarbari Ghosh, Madhurima Sarkar, Srabanti Hajra, Saptak Banerjee, Chiranjib Pal, Bhaskar Saha, Kalyan Kusum Mukherjee, Rathindranath Baral, Anamik